Zdrowie i gospodarka · 21/06/2000

FDA Amends Monograph for Over-the-Counter Ophthalmic Drug Products

The Food and Drug Administration (FDA) is updating the regulation for over-the-counter ophthalmic drug products, adding a new warning and revising an existing one for products containing ephedrine hydrochloride, naphazoline hydrochloride, phenylephrine hydrochloride, or tetrahydrozoline hydrochloride, used to treat minor eye irritations.